Endopharm

Endopharm, officially known as the Moscow Endocrine Plant, is a leading Russian state-owned pharmaceutical enterprise specializing in the development and large-scale production of high-tech medicines. The company serves as the primary supplier of narcotic analgesics and psychotropic substances, maintaining a critical role in the national healthcare infrastructure. Its extensive portfolio includes over 100 products across therapeutic areas such as ophthalmology, cardiology, and gynecology. Endopharm operates modern manufacturing facilities compliant with international GMP standards and is a central figure in domestic import substitution programs. The enterprise also provides contract manufacturing services and conducts research into both generic and innovative pharmaceutical formulations.